Clinical Proteomic Tumor Analysis Consortium (CPTAC) United States of America (USA)
Research
Date range: 1 November 2020 - 31 October 2021
Research collaboration: Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Clinical Proteomic Tumor Analysis Consortium (CPTAC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Broad Institute of MIT and Harvard
- Enterprise Science and Computing, Inc. (ESAC)
- Fred Hutchinson Cancer Research Center (FHCRC)
- Georgetown University Medical Center (GUMC)
- Harvard University
- Icahn School of Medicine at Mount Sinai (ISMMS), MSHS
- International Institute for Molecular Oncology (IIMO)
- Johns Hopkins University (JHU)
- Leidos Holdings, Inc.
- Massachusetts General Hospital (MGH)
- Massachusetts Institute of Technology (MIT)
- Memorial Sloan Kettering Cancer Center (MSKCC)
- NIH National Cancer Institute (NCI)
- NYU Langone Health
- National Institute of Standards and Technology (NIST)
- Pacific Northwest National Laboratory (PNNL)
- Spectragen Informatics (SGI)
- Stanford University
- The University of Chicago (UChicago)
- The University of North Carolina at Chapel Hill (UNC)
- University of Washington (UW)
- Vanderbilt University Medical Center (VUMC)
- Virginia Polytechnic Institute and State University (Virginia Tech)
- Washington University in St. Louis (WUSTL)